✦ LIBER ✦

Losartan leads to lower costs in T2DM and nephropathy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP2C9 variant modifies blood pressure-l

✍ M. Lajer; L. Tarnow; S. Andersen; H-H. Parving 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Injectable therapy in T2DM: real-world o

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

Lower stroke and MI risk with pioglitazo

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Losartan and the United States costs of

✍ Alexander, Charles M.; Lyle, Paulette A.; Keane, William F.; Carides, George W.; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 78 KB

Insulin Degludec Results in Consistently

✍ Russell-Jones, David L.; Del Prato, Stefano; Gall, Mari-Anne; Lassota, Nathan; D 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 69 KB

196: Cost-Effectiveness of Aliskiren as

✍ James L. Palmer; Veronica C. Munk; Robert W. Kotchie; Gabor Vincze; Alan Charney 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 184 KB